Skip to content
Recall Observatory FDA recall evidence

Device product

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

Z-1174-2024

December 28, 2023

Class II

Product summary

Firm
MRP, LLC dba Aquabiliti
Event
Event 93848
Status
Ongoing
Classification
Class II
Quantity
3,080,000 syringes
Official record key
device-enforcement:Z-1174-2024

Official wording

Reason: The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Code information: REF 2T0805 - Lot numbers KH04910, exp. 1/11/2024; KH04930, exp. 3/13/2024; KH04954, exp. 5/22/2024; KH04975, exp. 8/2/2024; KH04990, exp. 9/6/2024; KH05020, exp. 10/23/2024; KH05022, exp. 10/24/2024; KH05043, exp. 11/13/2024; KH05066, exp. 12/13/2024; KH05068, exp. 12/14/2024; KH05070, exp. 12/18/2024; KH05073, exp. 12/20/2024; KH05134, exp. 6/25/2025; KH05135, exp. 6/27/2025; and KH05152, exp. 10/10/2025; UDI-DI 10859809005013. REF 2T0807 - Lot numbers KH04909, exp. 1/10/2024; KH04944, exp. 4/24/2024; KH04986, exp. 8/30/2024; KH04988, exp. 9/5/2024; KH05024, exp. 10/25/2024; KH05026, exp. 10/26/2024; and KH05071, exp. 12/19/2024; UDI-DI 10859809005037.

Distribution pattern: US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

Field note

Send feedback

We'll only use this to respond to your feedback.